Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients

Condition:   Chronic Myelocytic Leukemia Intervention:   Other: RQ-PCR(Real-time Quantitative Polymerase chain reaction) RNA Analysis Sponsors:   Seoul St. Mary's Hospital;   Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials